Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan.
Oxid Med Cell Longev. 2013;2013:239854. doi: 10.1155/2013/239854. Epub 2013 Apr 18.
Endoplasmic reticulum (ER) stress has been known to be involved in the pathogenesis of various diseases, particularly neurodegenerative disorders such as Parkinson's disease (PD). We previously identified the human ubiquitin ligase HRD1 that is associated with protection against ER stress and its associated apoptosis. HRD1 promotes the ubiquitination and degradation of Parkin-associated endothelin receptor-like receptor (Pael-R), an ER stress inducer and causative factor of familial PD, thereby preventing Pael-R-induced neuronal cell death. Moreover, upregulation of HRD1 by the antiepileptic drug zonisamide suppresses 6-hydroxydopamine-induced neuronal cell death. We review recent progress in the studies on the mechanism of ER stress-induced neuronal death related to PD, particularly focusing on the involvement of HRD1 in the prevention of neuronal death as well as a potential therapeutic approach for PD based on the upregulation of HRD1.
内质网(ER)应激已被证实与多种疾病的发病机制有关,特别是帕金森病(PD)等神经退行性疾病。我们之前鉴定出与 ER 应激及其相关凋亡有关的人类泛素连接酶 HRD1。HRD1 促进与 ER 应激诱导剂和家族性 PD 的致病因子 Pael-R 相关的 Parkin 相关内皮素受体样受体(Pael-R)的泛素化和降解,从而防止 Pael-R 诱导的神经元细胞死亡。此外,抗癫痫药物佐米曲坦通过上调 HRD1 抑制 6-羟多巴胺诱导的神经元细胞死亡。我们综述了与 PD 相关的 ER 应激诱导神经元死亡机制的最新研究进展,特别是关注 HRD1 在预防神经元死亡中的作用以及基于 HRD1 上调的 PD 潜在治疗方法。